Phenotypic and Functional Profiles of Antigen-Specific CD4+ and CD8+ T Cells Associated With Infection Control in Patients With Cutaneous Leishmaniasis

The host immunological response is a key factor determining the pathogenesis of cutaneous leishmaniasis. It is known that a Th1 cellular response is associated with infection control and that antigen-specific memory T cells are necessary for the development of a rapid and strong protective cellular...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in cellular and infection microbiology Vol. 8; p. 393
Main Authors Egui, Adriana, Ledesma, Darién, Pérez-Antón, Elena, Montoya, Andrés, Gómez, Inmaculada, Robledo, Sara María, Infante, Juan José, Vélez, Ivan Darío, López, Manuel C., Thomas, M. Carmen
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 19.11.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The host immunological response is a key factor determining the pathogenesis of cutaneous leishmaniasis. It is known that a Th1 cellular response is associated with infection control and that antigen-specific memory T cells are necessary for the development of a rapid and strong protective cellular response. The present manuscript reports the analysis of the functional and phenotypic profiles of antigen-specific CD4 and CD8 T cells from patients cured of cutaneous leishmaniasis (CL), patients with an active process of cutaneous leishmaniasis, asymptomatic individuals with a positive Montenegro test and healthy donors (HD). Peripheral blood mononuclear cells (PBMCs) from the patients exhibited a lymphoproliferative capacity after stimulation with total soluble protein from either (S A) or (S A) or with a recombinant paraflagellar rod protein-1 (rPFR1). Higher frequencies of antigen-specific T cells, mainly following stimulation with rPFR1, were observed in asymptomatic and cured patients than in patients with active cutaneous leishmaniasis, while T cells from patients with active cutaneous leishmaniasis showed a higher percentage of effector memory T cells (T for CD4 T cells and T for CD8 T cells). The amount of antigen-specific CD57 /CD8 T cells in patients with active cutaneous leishmaniasis was higher than that in cured patients and asymptomatic subjects. Regarding functionality, a more robust multifunctional CD8 T cell response was detected in cured patients than in those with active cutaneous leishmaniasis. Moreover, cured patients showed a significant increase in the frequency of cells expressing a Th1-type cytotoxic production profile (IFN-γ /granzyme-B/ perforin ). Patients with an active leishmaniosis process had a significantly higher frequency of CD8 T cells expressing the inhibitory CD160 and 2B4 receptors than did cured patients. The expression profile observed in cured patients could be indicative of an imbalance toward a CD8 Th1 response, which could be associated with infection control; consequently, the determination of this profile could be a useful tool for facilitating the clinical follow-up of patients with cutaneous leishmaniasis. The results also suggest a possible exhaustion process of CD8 T cells associated with the evolution of infection.
AbstractList The host immunological response is a key factor determining the pathogenesis of cutaneous leishmaniasis. It is known that a Th1 cellular response is associated with infection control and that antigen-specific memory T cells are necessary for the development of a rapid and strong protective cellular response. The present manuscript reports the analysis of the functional and phenotypic profiles of antigen-specific CD4+ and CD8+ T cells from patients cured of cutaneous leishmaniasis (CL), patients with an active process of cutaneous leishmaniasis, asymptomatic individuals with a positive Montenegro test and healthy donors (HD). Peripheral blood mononuclear cells (PBMCs) from the patients exhibited a lymphoproliferative capacity after stimulation with total soluble protein from either Leishmania panamensis (SLpA) or Leishmania infantum (SLiA) or with a recombinant paraflagellar rod protein-1 (rPFR1). Higher frequencies of antigen-specific TNAIVE cells, mainly following stimulation with rPFR1, were observed in asymptomatic and cured patients than in patients with active cutaneous leishmaniasis, while T cells from patients with active cutaneous leishmaniasis showed a higher percentage of effector memory T cells (TEM for CD4+ T cells and TEMRA for CD8+ T cells). The amount of antigen-specific CD57+/CD8+ TEMRA cells in patients with active cutaneous leishmaniasis was higher than that in cured patients and asymptomatic subjects. Regarding functionality, a more robust multifunctional CD8+ T cell response was detected in cured patients than in those with active cutaneous leishmaniasis. Moreover, cured patients showed a significant increase in the frequency of cells expressing a Th1-type cytotoxic production profile (IFN-γ+/granzyme-B/+perforin+). Patients with an active leishmaniosis process had a significantly higher frequency of CD8+ T cells expressing the inhibitory CD160 and 2B4 receptors than did cured patients. The expression profile observed in cured patients could be indicative of an imbalance toward a CD8+ Th1 response, which could be associated with infection control; consequently, the determination of this profile could be a useful tool for facilitating the clinical follow-up of patients with cutaneous leishmaniasis. The results also suggest a possible exhaustion process of CD8+ T cells associated with the evolution of Leishmania infection.The host immunological response is a key factor determining the pathogenesis of cutaneous leishmaniasis. It is known that a Th1 cellular response is associated with infection control and that antigen-specific memory T cells are necessary for the development of a rapid and strong protective cellular response. The present manuscript reports the analysis of the functional and phenotypic profiles of antigen-specific CD4+ and CD8+ T cells from patients cured of cutaneous leishmaniasis (CL), patients with an active process of cutaneous leishmaniasis, asymptomatic individuals with a positive Montenegro test and healthy donors (HD). Peripheral blood mononuclear cells (PBMCs) from the patients exhibited a lymphoproliferative capacity after stimulation with total soluble protein from either Leishmania panamensis (SLpA) or Leishmania infantum (SLiA) or with a recombinant paraflagellar rod protein-1 (rPFR1). Higher frequencies of antigen-specific TNAIVE cells, mainly following stimulation with rPFR1, were observed in asymptomatic and cured patients than in patients with active cutaneous leishmaniasis, while T cells from patients with active cutaneous leishmaniasis showed a higher percentage of effector memory T cells (TEM for CD4+ T cells and TEMRA for CD8+ T cells). The amount of antigen-specific CD57+/CD8+ TEMRA cells in patients with active cutaneous leishmaniasis was higher than that in cured patients and asymptomatic subjects. Regarding functionality, a more robust multifunctional CD8+ T cell response was detected in cured patients than in those with active cutaneous leishmaniasis. Moreover, cured patients showed a significant increase in the frequency of cells expressing a Th1-type cytotoxic production profile (IFN-γ+/granzyme-B/+perforin+). Patients with an active leishmaniosis process had a significantly higher frequency of CD8+ T cells expressing the inhibitory CD160 and 2B4 receptors than did cured patients. The expression profile observed in cured patients could be indicative of an imbalance toward a CD8+ Th1 response, which could be associated with infection control; consequently, the determination of this profile could be a useful tool for facilitating the clinical follow-up of patients with cutaneous leishmaniasis. The results also suggest a possible exhaustion process of CD8+ T cells associated with the evolution of Leishmania infection.
The host immunological response is a key factor determining the pathogenesis of cutaneous leishmaniasis. It is known that a Th1 cellular response is associated with infection control and that antigen-specific memory T cells are necessary for the development of a rapid and strong protective cellular response. The present manuscript reports the analysis of the functional and phenotypic profiles of antigen-specific CD4 and CD8 T cells from patients cured of cutaneous leishmaniasis (CL), patients with an active process of cutaneous leishmaniasis, asymptomatic individuals with a positive Montenegro test and healthy donors (HD). Peripheral blood mononuclear cells (PBMCs) from the patients exhibited a lymphoproliferative capacity after stimulation with total soluble protein from either (S A) or (S A) or with a recombinant paraflagellar rod protein-1 (rPFR1). Higher frequencies of antigen-specific T cells, mainly following stimulation with rPFR1, were observed in asymptomatic and cured patients than in patients with active cutaneous leishmaniasis, while T cells from patients with active cutaneous leishmaniasis showed a higher percentage of effector memory T cells (T for CD4 T cells and T for CD8 T cells). The amount of antigen-specific CD57 /CD8 T cells in patients with active cutaneous leishmaniasis was higher than that in cured patients and asymptomatic subjects. Regarding functionality, a more robust multifunctional CD8 T cell response was detected in cured patients than in those with active cutaneous leishmaniasis. Moreover, cured patients showed a significant increase in the frequency of cells expressing a Th1-type cytotoxic production profile (IFN-γ /granzyme-B/ perforin ). Patients with an active leishmaniosis process had a significantly higher frequency of CD8 T cells expressing the inhibitory CD160 and 2B4 receptors than did cured patients. The expression profile observed in cured patients could be indicative of an imbalance toward a CD8 Th1 response, which could be associated with infection control; consequently, the determination of this profile could be a useful tool for facilitating the clinical follow-up of patients with cutaneous leishmaniasis. The results also suggest a possible exhaustion process of CD8 T cells associated with the evolution of infection.
The host immunological response is a key factor determining the pathogenesis of cutaneous leishmaniasis. It is known that a Th1 cellular response is associated with infection control and that antigen-specific memory T cells are necessary for the development of a rapid and strong protective cellular response. The present manuscript reports the analysis of the functional and phenotypic profiles of antigen-specific CD4 + and CD8 + T cells from patients cured of cutaneous leishmaniasis (CL), patients with an active process of cutaneous leishmaniasis, asymptomatic individuals with a positive Montenegro test and healthy donors (HD). Peripheral blood mononuclear cells (PBMCs) from the patients exhibited a lymphoproliferative capacity after stimulation with total soluble protein from either Leishmania panamensis (S Lp A) or Leishmania infantum (S Li A) or with a recombinant paraflagellar rod protein-1 (rPFR1). Higher frequencies of antigen-specific T NAIVE cells, mainly following stimulation with rPFR1, were observed in asymptomatic and cured patients than in patients with active cutaneous leishmaniasis, while T cells from patients with active cutaneous leishmaniasis showed a higher percentage of effector memory T cells (T EM for CD4 + T cells and T EMRA for CD8 + T cells). The amount of antigen-specific CD57 + /CD8 + T EMRA cells in patients with active cutaneous leishmaniasis was higher than that in cured patients and asymptomatic subjects. Regarding functionality, a more robust multifunctional CD8 + T cell response was detected in cured patients than in those with active cutaneous leishmaniasis. Moreover, cured patients showed a significant increase in the frequency of cells expressing a Th1-type cytotoxic production profile (IFN-γ + /granzyme-B/ + perforin + ). Patients with an active leishmaniosis process had a significantly higher frequency of CD8 + T cells expressing the inhibitory CD160 and 2B4 receptors than did cured patients. The expression profile observed in cured patients could be indicative of an imbalance toward a CD8 + Th1 response, which could be associated with infection control; consequently, the determination of this profile could be a useful tool for facilitating the clinical follow-up of patients with cutaneous leishmaniasis. The results also suggest a possible exhaustion process of CD8 + T cells associated with the evolution of Leishmania infection.
The host immunological response is a key factor determining the pathogenesis of cutaneous leishmaniasis. It is known that a Th1 cellular response is associated with infection control and that antigen-specific memory T cells are necessary for the development of a rapid and strong protective cellular response. The present manuscript reports the analysis of the functional and phenotypic profiles of antigen-specific CD4+ and CD8+ T cells from patients cured of cutaneous leishmaniasis (CL), patients with an active process of cutaneous leishmaniasis, asymptomatic individuals with a positive Montenegro test and healthy donors (HD). Peripheral blood mononuclear cells (PBMCs) from the patients exhibited a lymphoproliferative capacity after stimulation with total soluble protein from either Leishmania panamensis (SLpA) or Leishmania infantum (SLiA) or with a recombinant paraflagellar rod protein-1 (rPFR1). Higher frequencies of antigen-specific TNAIVE cells, mainly following stimulation with rPFR1, were observed in asymptomatic and cured patients than in patients with active cutaneous leishmaniasis, while T cells from patients with active cutaneous leishmaniasis showed a higher percentage of effector memory T cells (TEM for CD4+ T cells and TEMRA for CD8+ T cells). The amount of antigen-specific CD57+/CD8+ TEMRA cells in patients with active cutaneous leishmaniasis was higher than that in cured patients and asymptomatic subjects. Regarding functionality, a more robust multifunctional CD8+ T cell response was detected in cured patients than in those with active cutaneous leishmaniasis. Moreover, cured patients showed a significant increase in the frequency of cells expressing a Th1-type cytotoxic production profile (IFN-γ+/granzyme-B/+perforin+). Patients with an active leishmaniosis process had a significantly higher frequency of CD8+ T cells expressing the inhibitory CD160 and 2B4 receptors than did cured patients. The expression profile observed in cured patients could be indicative of an imbalance toward a CD8+ Th1 response, which could be associated with infection control; consequently, the determination of this profile could be a useful tool for facilitating the clinical follow-up of patients with cutaneous leishmaniasis. The results also suggest a possible exhaustion process of CD8+ T cells associated with the evolution of Leishmania infection.
Author Gómez, Inmaculada
Infante, Juan José
Pérez-Antón, Elena
Robledo, Sara María
Ledesma, Darién
Vélez, Ivan Darío
López, Manuel C.
Egui, Adriana
Thomas, M. Carmen
Montoya, Andrés
AuthorAffiliation 3 Bionaturis Group, Bioorganic Research and Services, S.A. , Jerez de la Frontera , Spain
2 Programa de Estudio y Control de Enfermedades Tropicales, Facultad de Medicina, Universidad de Antioquia , Medellín , Colombia
1 Molecular Biology Department, Instituto de Parasitología y Biomedicina “López Neyra”, Consejo Superior de Investigaciones Científicas , Granada , Spain
AuthorAffiliation_xml – name: 3 Bionaturis Group, Bioorganic Research and Services, S.A. , Jerez de la Frontera , Spain
– name: 2 Programa de Estudio y Control de Enfermedades Tropicales, Facultad de Medicina, Universidad de Antioquia , Medellín , Colombia
– name: 1 Molecular Biology Department, Instituto de Parasitología y Biomedicina “López Neyra”, Consejo Superior de Investigaciones Científicas , Granada , Spain
Author_xml – sequence: 1
  givenname: Adriana
  surname: Egui
  fullname: Egui, Adriana
– sequence: 2
  givenname: Darién
  surname: Ledesma
  fullname: Ledesma, Darién
– sequence: 3
  givenname: Elena
  surname: Pérez-Antón
  fullname: Pérez-Antón, Elena
– sequence: 4
  givenname: Andrés
  surname: Montoya
  fullname: Montoya, Andrés
– sequence: 5
  givenname: Inmaculada
  surname: Gómez
  fullname: Gómez, Inmaculada
– sequence: 6
  givenname: Sara María
  surname: Robledo
  fullname: Robledo, Sara María
– sequence: 7
  givenname: Juan José
  surname: Infante
  fullname: Infante, Juan José
– sequence: 8
  givenname: Ivan Darío
  surname: Vélez
  fullname: Vélez, Ivan Darío
– sequence: 9
  givenname: Manuel C.
  surname: López
  fullname: López, Manuel C.
– sequence: 10
  givenname: M. Carmen
  surname: Thomas
  fullname: Thomas, M. Carmen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30510917$$D View this record in MEDLINE/PubMed
BookMark eNp1kl1rFDEUhoNUbF1775XkUiiz5msmkxthmVpdWHDBipchk0l2U2aSdZIR-kv8u2Z3WmkFc5Ov931Ocs55Dc588AaAtxgtKa3FB6vd0C4JwvUSISroC3BBCC0LIur67Mn6HFzGeIfy4IjUgr4C5xSVGAnML8Dv7d74kO4PTkPlO3gzeZ1c8KqH2zFY15sIg4Urn9zO-OLbwWhns7a5ZlcnQ3NdX8Fb2Ji-j3AVY9BOJdPBHy7t4dpbc8LBJvg0hh46D7cqOeNTnCXNlJQ3YYpwY1zcD8o7FV18A15a1Udz-TAvwPebT7fNl2Lz9fO6WW0KzSqSCo2VKRlC2ppOa17RTvEac9GiNu8MYx23tLWVqjvDcMuxtpga2wpRKdXqki7AeuZ2Qd3Jw-gGNd7LoJw8HYRxJ9WYnO6NFC1tkSBI8IqzWhFBuO0qZkud1115ZH2cWYepHfJ78idH1T-DPr_xbi934ZesSEkoZRnw_gEwhp-TiUkOLuqc2TlDkmAm6orxrF6Ad09j_Q3yWNksqGaBHkOMo7FSu6SOtcihXS8xkscukqcukscukqcuykb0j_GR_V_LHwaBzTU
CitedBy_id crossref_primary_10_3389_fimmu_2021_620144
crossref_primary_10_3389_fimmu_2021_632667
crossref_primary_10_1371_journal_pntd_0011474
crossref_primary_10_3390_microorganisms8071069
crossref_primary_10_1002_cti2_1178
crossref_primary_10_1002_cti2_1396
crossref_primary_10_3389_fcimb_2021_639801
crossref_primary_10_1128_mbio_03309_21
crossref_primary_10_1186_s13071_024_06573_2
crossref_primary_10_3389_fcimb_2024_1439714
crossref_primary_10_1007_s00430_021_00703_8
crossref_primary_10_1016_j_intimp_2021_108400
crossref_primary_10_3390_vaccines11071129
crossref_primary_10_3390_vaccines7040156
crossref_primary_10_1016_j_micpath_2023_106202
crossref_primary_10_1016_j_cellimm_2020_104196
crossref_primary_10_1080_14789450_2022_2131545
crossref_primary_10_1371_journal_pntd_0008093
crossref_primary_10_1038_s41419_023_05848_3
crossref_primary_10_3390_pathogens13060460
crossref_primary_10_3390_pharmaceutics14122642
crossref_primary_10_15789_2220_7619_ARB_1550
crossref_primary_10_3389_fimmu_2024_1304696
crossref_primary_10_3389_fimmu_2023_1231836
crossref_primary_10_1016_j_cimid_2020_101542
crossref_primary_10_3389_fmicb_2021_734355
crossref_primary_10_3390_v13050729
Cites_doi 10.1371/journal.pntd.0002567
10.1002/eji.201040384
10.1371/journal.pone.0035671
10.1128/IAI.62.6.2614-2618.1994
10.1086/340261
10.1590/S0074-02762007000100013
10.1016/S0035-9203(02)90071-4
10.1007/s10875-012-9788-7
10.7705/biomedica.v26i1.1508
10.1371/journal.pone.0122115
10.1038/35065118
10.1007/s12026-008-8016-2
10.1111/j.1365-2133.2005.06647.x
10.1038/nm1108
10.1016/j.celrep.2014.06.012
10.1038/srep28266
10.4049/jimmunol.1202537
10.1016/0140-6736(90)91945-7
10.1038/nrmicro2608
10.1128/AAC.04298-14
10.7705/biomedica.v28i4.66
10.1128/IAI.59.8.2839-2842.1991
10.1189/jlb.0208107
10.1186/s12917-017-1224-z
10.1016/j.virol.2014.12.033
10.3389/fpubh.2014.00165
10.1016/S0166-6851(97)00149-7
10.1128/CDLI.9.2.251-256.2002
10.1093/infdis/jit401
10.1016/0248-4900(88)90056-1
10.1590/S0100-879X1998000100019
10.1016/j.trstmh.2006.02.014
10.1371/journal.ppat.1000431
10.3390/ijms18081742
10.1128/IAI.62.3.837-842.1994
10.1038/nri933
10.1016/j.imbio.2016.03.007
10.1371/journal.pntd.0001204
10.1016/j.cellimm.2016.07.010
10.1128/IAI.61.1.220-226.1993
10.1128/IAI.02404-14
10.1371/journal.pntd.0000871
10.4049/jimmunol.1602095
10.4049/jimmunol.166.6.4012
10.1086/382135
10.1016/j.vaccine.2006.07.006
10.1086/600109
10.1111/cei.12798
10.1371/journal.pntd.0000512
10.1084/jem.20030159
10.3389/fimmu.2018.01021
10.1590/S0100-879X1998000100020
10.1038/jid.2013.4
10.1128/IAI.71.6.3165-3171.2003
10.1128/JCM.29.4.757-763.1991
10.1111/j.1365-3024.2007.00991.x
10.4269/ajtmh.1990.42.206
10.1155/2014/636039
10.1111/j.1365-3024.2009.01125.x
10.4049/jimmunol.1500459
10.1007/s40257-015-0114-z
10.1371/journal.pntd.0004178
10.1002/eji.200939451
10.1371/journal.ppat.1003504
10.3389/fimmu.2016.00151
10.4049/jimmunol.1301810
10.1111/j.1365-3024.2009.01116.x
10.1016/j.molimm.2012.05.021
10.1016/j.micinf.2012.02.006
10.1146/annurev.immunol.22.012703.104702
10.1002/eji.200535458
10.1016/j.pt.2012.07.001
ContentType Journal Article
Copyright Copyright © 2018 Egui, Ledesma, Pérez-Antón, Montoya, Gómez, Robledo, Infante, Vélez, López and Thomas. 2018 Egui, Ledesma, Pérez-Antón, Montoya, Gómez, Robledo, Infante, Vélez, López and Thomas
Copyright_xml – notice: Copyright © 2018 Egui, Ledesma, Pérez-Antón, Montoya, Gómez, Robledo, Infante, Vélez, López and Thomas. 2018 Egui, Ledesma, Pérez-Antón, Montoya, Gómez, Robledo, Infante, Vélez, López and Thomas
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fcimb.2018.00393
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2235-2988
ExternalDocumentID oai_doaj_org_article_9b3b0920976748a2927fd64f5ca29d55
PMC6252334
30510917
10_3389_fcimb_2018_00393
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
AIAGR
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
INR
KQ8
M48
M~E
OK1
PGMZT
RPM
IAO
IEA
IHR
IHW
INH
IPNFZ
ISR
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c462t-c1ae5400cfedcc763da78179b0bc76e44d7f3bf6a8de41b71cf13efb996aabc53
IEDL.DBID M48
ISSN 2235-2988
IngestDate Wed Aug 27 01:14:35 EDT 2025
Thu Aug 21 18:20:54 EDT 2025
Fri Jul 11 01:48:25 EDT 2025
Thu Jan 02 23:00:56 EST 2025
Tue Jul 01 04:32:18 EDT 2025
Thu Apr 24 23:06:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords phenotype
Th1-cytokines
paraflagellar rod protein-1
Leishmania
biomarkers
inhibitory receptors
CD8+ and CD4+ T-cells
leishmaniasis
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-c1ae5400cfedcc763da78179b0bc76e44d7f3bf6a8de41b71cf13efb996aabc53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Parasite and Host, a section of the journal Frontiers in Cellular and Infection Microbiology
Reviewed by: Hira Nakhasi, Center for Biologics Evaluation and Research (FDA), United States; Javier Moreno, Instituto de Salud Carlos III, Spain; Vicente Larraga, Department of Cellular and Molecular Biology, Consejo Superior de Investigaciones Científicas (CSIC), Spain
Edited by: Eugenia Carrillo, Instituto de Salud Carlos III, Spain
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fcimb.2018.00393
PMID 30510917
PQID 2149864752
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_9b3b0920976748a2927fd64f5ca29d55
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6252334
proquest_miscellaneous_2149864752
pubmed_primary_30510917
crossref_citationtrail_10_3389_fcimb_2018_00393
crossref_primary_10_3389_fcimb_2018_00393
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-11-19
PublicationDateYYYYMMDD 2018-11-19
PublicationDate_xml – month: 11
  year: 2018
  text: 2018-11-19
  day: 19
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in cellular and infection microbiology
PublicationTitleAlternate Front Cell Infect Microbiol
PublicationYear 2018
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Ramírez (B57) 2016; 6
Barroso (B5) 2018; 9
Michailowsky (B48) 2003; 71
Von Stebut (B69) 2003; 198
Esch (B24) 2013; 191
Naouar (B52) 2014; 2014
Ruiz (B61) 2007; 29
Sallusto (B63) 2004; 22
Aebischer (B1) 1993; 61
Chattopadhyay (B10) 2009; 85
de Vries (B21) 2015; 16
Arias (B3) 2014; 8
Jayakumar (B33) 2011; 5
Mateus (B45) 2017; 198
Corredor (B12) 1990; 42
Ledesma (B43) 2017; 13
Santrich (B65) 1997; 90
Zaph (B73) 2004; 10
Khamesipour (B38) 2012; 14
B70
De Luca (B18) 2016; 7
Egui (B23) 2012; 52
Hernández-Ruiz (B32) 2010; 4
Robinson (B59) 2002; 96
Alvar (B2) 2012; 7
Morell (B50) 2006; 24
Okwor (B54) 2008; 41
Castilho (B8) 2010; 40
Pinheiro (B56) 2007; 102
Santos Cda (B64) 2013; 133
Mou (B51) 2013; 190
Rodrigues (B60) 2014; 8
Coutinho (B13) 1998; 31
Gigley (B30) 2012; 28
Novais (B53) 2013; 9
Sacks (B62) 2002; 2
Cachon (B6) 1988; 63
Follador (B28) 2002; 34
Ovalle (B55) 2006; 26
da Silva Santos (B14) 2014; 2
Xu (B72) 2017; 18
Fiuza (B27) 2009; 3
Saravia (B66) 1990; 336
Lakhal-Naouar (B40) 2015; 9
Laskay (B41) 1991; 29
Bangham (B4) 2009; 39
Chiku (B11) 2016; 221
Kip (B39) 2015; 59
Cardoso (B7) 2015; 83
Silveira (B67) 2009; 31
Kahan (B35) 2015; 480
Da-Cruz (B17) 1994; 62
Lasso (B42) 2015; 195
de Oliveira Camera (B19) 2006; 100
Keshavarz Valian (B37) 2013; 33
Ribeiro-de-Jesus (B58) 1998; 31
Joshi (B34) 2009; 5
Da-Cruz (B15) 2005; 153
Champagne (B9) 2001; 410
Melby (B46) 1994; 62
Mendonça (B47) 2004; 189
Egui (B22) 2015; 10
de Oliveira Mendes-Aguiar (B20) 2016; 185
Kaye (B36) 2011; 9
Gautam (B29) 2014; 209
Da-Cruz (B16) 2002; 9
Faria (B25) 2009; 31
Montalvo (B49) 2008; 28
Wilhelm (B71) 2001; 166
Figueroa (B26) 2009; 200
Glennie (B31) 2016; 309
Theodos (B68) 1991; 59
Liang (B44) 2006; 36
References_xml – volume: 8
  start-page: e2567
  year: 2014
  ident: B60
  article-title: Impairment of T cell function in parasitic infections
  publication-title: PLoS Negl. Trop. Dis
  doi: 10.1371/journal.pntd.0002567
– volume: 40
  start-page: 2816
  year: 2010
  ident: B8
  article-title: Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease
  publication-title: Eur. J. Immunol
  doi: 10.1002/eji.201040384
– volume: 7
  start-page: e35671
  year: 2012
  ident: B2
  article-title: Leishmaniasis worldwide and global estimates of its incidence
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0035671
– volume: 62
  start-page: 2614
  year: 1994
  ident: B17
  article-title: Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis
  publication-title: Infect. Immun
  doi: 10.1128/IAI.62.6.2614-2618.1994
– volume: 34
  start-page: E54
  year: 2002
  ident: B28
  article-title: Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection
  publication-title: Clin. Infect. Dis
  doi: 10.1086/340261
– volume: 102
  start-page: 79
  year: 2007
  ident: B56
  article-title: Interferon-gamma is required for the late but not early control of Leishmania amazonensis infection in C57Bl/6 mice
  publication-title: Mem. Inst. Oswaldo Cruz
  doi: 10.1590/S0074-02762007000100013
– volume: 96
  start-page: S169
  year: 2002
  ident: B59
  article-title: The method used to sample ulcers influences the diagnosis of cutaneous Leishmaniasis
  publication-title: Trans. R. Soc. Trop. Med. Hyg
  doi: 10.1016/S0035-9203(02)90071-4
– volume: 33
  start-page: 220
  year: 2013
  ident: B37
  article-title: CCR7+ central and CCR7- effector memory CD4+ T cells in human cutaneous leishmaniasis
  publication-title: J. Clin. Immunol
  doi: 10.1007/s10875-012-9788-7
– volume: 26
  start-page: 145
  year: 2006
  ident: B55
  article-title: [Geographic distribution of Leishmania species isolated from patients at the National Institute of Dermatology Federico Lleras Acosta E.S.E., 1995-2005]
  publication-title: Biomedica
  doi: 10.7705/biomedica.v26i1.1508
– volume: 10
  start-page: e0122115
  year: 2015
  ident: B22
  article-title: Differential phenotypic and functional profiles of TcCA-2 -specific cytotoxic CD8+ T cells in the asymptomatic versus cardiac phase in Chagasic patients
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0122115
– volume: 410
  start-page: 106
  year: 2001
  ident: B9
  article-title: Skewed maturation of memory HIV-specific CD8 T lymphocytes
  publication-title: Nature
  doi: 10.1038/35065118
– volume: 41
  start-page: 123
  year: 2008
  ident: B54
  article-title: Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies
  publication-title: Immunol. Res
  doi: 10.1007/s12026-008-8016-2
– volume: 153
  start-page: 537
  year: 2005
  ident: B15
  article-title: Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions
  publication-title: Br. J. Dermatol
  doi: 10.1111/j.1365-2133.2005.06647.x
– volume: 10
  start-page: 1104
  year: 2004
  ident: B73
  article-title: Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites
  publication-title: Nat. Med
  doi: 10.1038/nm1108
– volume: 8
  start-page: 420
  year: 2014
  ident: B3
  article-title: Elucidating sources and roles of granzymes A and B during bacterial infection and sepsis
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2014.06.012
– volume: 6
  start-page: 28266
  year: 2016
  ident: B57
  article-title: Taxonomy, diversity, temporal and geographical distribution of Cutaneous Leishmaniasis in Colombia: a retrospective study
  publication-title: Sci. Rep
  doi: 10.1038/srep28266
– volume: 190
  start-page: 3380
  year: 2013
  ident: B51
  article-title: Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.1202537
– volume: 336
  start-page: 398
  year: 1990
  ident: B66
  article-title: Recurrent lesions in human Leishmania braziliensis infection–reactivation or reinfection?
  publication-title: Lancet
  doi: 10.1016/0140-6736(90)91945-7
– volume: 9
  start-page: 604
  year: 2011
  ident: B36
  article-title: Leishmaniasis: complexity at the host-pathogen interface
  publication-title: Nat. Rev. Microbiol
  doi: 10.1038/nrmicro2608
– volume: 59
  start-page: 1
  year: 2015
  ident: B39
  article-title: Systematic review of biomarkers to monitor therapeutic response in leishmaniasis
  publication-title: Antimicrob. Agents Chemother
  doi: 10.1128/AAC.04298-14
– volume: 28
  start-page: 597
  year: 2008
  ident: B49
  article-title: [PCR-RFLP and RAPD for typing neotropical Leishmania]
  publication-title: Biomedica
  doi: 10.7705/biomedica.v28i4.66
– volume: 59
  start-page: 2839
  year: 1991
  ident: B68
  article-title: Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo
  publication-title: Infect. Immun
  doi: 10.1128/IAI.59.8.2839-2842.1991
– volume: 85
  start-page: 88
  year: 2009
  ident: B10
  article-title: The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression
  publication-title: J. Leukoc. Biol
  doi: 10.1189/jlb.0208107
– volume: 13
  start-page: 304
  year: 2017
  ident: B43
  article-title: Performance of Leishmania PFR1 recombinant antigen in serological diagnosis of asymptomatic canine leishmaniosis by ELISA
  publication-title: BMC Vet. Res
  doi: 10.1186/s12917-017-1224-z
– volume: 480
  start-page: 180
  year: 2015
  ident: B35
  article-title: T cell exhaustion during persistent viral infections
  publication-title: Virology
  doi: 10.1016/j.virol.2014.12.033
– volume: 2
  start-page: 165
  year: 2014
  ident: B14
  article-title: The role of CD4 and CD8 T cells in human cutaneous Leishmaniasis
  publication-title: Front. Public Health
  doi: 10.3389/fpubh.2014.00165
– volume: 90
  start-page: 95
  year: 1997
  ident: B65
  article-title: A motility function for the paraflagellar rod of Leishmania parasites revealed by PFR-2 gene knockouts
  publication-title: Mol. Biochem. Parasitol
  doi: 10.1016/S0166-6851(97)00149-7
– volume: 9
  start-page: 251
  year: 2002
  ident: B16
  article-title: T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy
  publication-title: Clin. Diagn. Lab. Immunol
  doi: 10.1128/CDLI.9.2.251-256.2002
– volume: 209
  start-page: 290
  year: 2014
  ident: B29
  article-title: CD8 T cell exhaustion in human visceral leishmaniasis
  publication-title: J. Infect. Dis
  doi: 10.1093/infdis/jit401
– volume: 63
  start-page: 169
  year: 1988
  ident: B6
  article-title: The paraflagellar rod: a structure in search of a function
  publication-title: Biol. Cell
  doi: 10.1016/0248-4900(88)90056-1
– volume: 31
  start-page: 139
  year: 1998
  ident: B13
  article-title: Immunologic patterns associated with cure in human American cutaneous leishmaniasis
  publication-title: Braz. J. Med. Biol. Res
  doi: 10.1590/S0100-879X1998000100019
– volume: 100
  start-page: 1112
  year: 2006
  ident: B19
  article-title: Haematogenous dissemination of Leishmania (Viannia) braziliensis in human American tegumentary leishmaniasis
  publication-title: Trans. R. Soc. Trop. Med. Hyg
  doi: 10.1016/j.trstmh.2006.02.014
– volume: 5
  start-page: e1000431
  year: 2009
  ident: B34
  article-title: B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1000431
– volume: 18
  start-page: 1742
  year: 2017
  ident: B72
  article-title: Markers of T cell senescence in humans
  publication-title: Int. J. Mol. Sci
  doi: 10.3390/ijms18081742
– volume: 62
  start-page: 837
  year: 1994
  ident: B46
  article-title: Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis
  publication-title: Infect. Immun
  doi: 10.1128/IAI.62.3.837-842.1994
– volume: 2
  start-page: 845
  year: 2002
  ident: B62
  article-title: The immunology of susceptibility and resistance to Leishmania major in mice
  publication-title: Nat. Rev. Immunol
  doi: 10.1038/nri933
– volume: 221
  start-page: 879
  year: 2016
  ident: B11
  article-title: PD-1 function in apoptosis of T lymphocytes in canine visceral leishmaniasis
  publication-title: Immunobiology
  doi: 10.1016/j.imbio.2016.03.007
– volume: 5
  start-page: e1204
  year: 2011
  ident: B33
  article-title: TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia)
  publication-title: PLoS Negl. Trop. Dis
  doi: 10.1371/journal.pntd.0001204
– volume: 309
  start-page: 50
  year: 2016
  ident: B31
  article-title: Memory T cells in cutaneous leishmaniasis
  publication-title: Cell Immunol
  doi: 10.1016/j.cellimm.2016.07.010
– volume: 61
  start-page: 220
  year: 1993
  ident: B1
  article-title: Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host
  publication-title: Infect. Immun
  doi: 10.1128/IAI.61.1.220-226.1993
– volume: 83
  start-page: 898
  year: 2015
  ident: B7
  article-title: Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection
  publication-title: Infect. Immun
  doi: 10.1128/IAI.02404-14
– volume: 4
  start-page: e871
  year: 2010
  ident: B32
  article-title: CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists
  publication-title: PLoS Negl. Trop. Dis
  doi: 10.1371/journal.pntd.0000871
– volume: 198
  start-page: 3170
  year: 2017
  ident: B45
  article-title: Antiparasitic treatment induces an improved CD8(+) T cell response in chronic chagasic patients
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.1602095
– volume: 166
  start-page: 4012
  year: 2001
  ident: B71
  article-title: Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.166.6.4012
– volume: 189
  start-page: 1018
  year: 2004
  ident: B47
  article-title: Persistence of leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure?
  publication-title: J. Infect. Dis
  doi: 10.1086/382135
– volume: 24
  start-page: 7046
  year: 2006
  ident: B50
  article-title: The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2006.07.006
– volume: 200
  start-page: 638
  year: 2009
  ident: B26
  article-title: Detection of Leishmania in unaffected mucosal tissues of patients with cutaneous leishmaniasis caused by Leishmania (Viannia) species
  publication-title: J. Infect. Dis
  doi: 10.1086/600109
– volume: 185
  start-page: 202
  year: 2016
  ident: B20
  article-title: Effector memory CD4(+) T cells differentially express activation associated molecules depending on the duration of American cutaneous leishmaniasis lesions
  publication-title: Clin. Exp. Immunol
  doi: 10.1111/cei.12798
– volume: 3
  start-page: e512
  year: 2009
  ident: B27
  article-title: Profile of central and effector memory T cells in the progression of chronic human chagas disease
  publication-title: PLoS Negl. Trop. Dis
  doi: 10.1371/journal.pntd.0000512
– volume: 198
  start-page: 191
  year: 2003
  ident: B69
  article-title: Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice
  publication-title: J. Exp. Med
  doi: 10.1084/jem.20030159
– volume: 9
  start-page: 1021
  year: 2018
  ident: B5
  article-title: PD-L1 may mediate T-cell exhaustion in a case of early diffuse leishmaniasis caused by Leishmania (L.) amazonensis
  publication-title: Front. Immunol
  doi: 10.3389/fimmu.2018.01021
– volume: 31
  start-page: 143
  year: 1998
  ident: B58
  article-title: Cytokine profile and pathology in human leishmaniasis
  publication-title: Braz. J. Med. Biol. Res
  doi: 10.1590/S0100-879X1998000100020
– volume: 133
  start-page: 1533
  year: 2013
  ident: B64
  article-title: CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNgamma(+)-mediated parasite killing in human cutaneous leishmaniasis
  publication-title: J. Invest. Dermatol
  doi: 10.1038/jid.2013.4
– volume: 71
  start-page: 3165
  year: 2003
  ident: B48
  article-title: Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease
  publication-title: Infect. Immun
  doi: 10.1128/IAI.71.6.3165-3171.2003
– volume: 29
  start-page: 757
  year: 1991
  ident: B41
  article-title: Immune reactivity to fractionated Leishmania aethiopica antigens during active human infection
  publication-title: J. Clin. Microbiol
  doi: 10.1128/JCM.29.4.757-763.1991
– volume: 29
  start-page: 671
  year: 2007
  ident: B61
  article-title: CD8 cytotoxic T cells in cutaneous leishmaniasis
  publication-title: Parasite Immunol
  doi: 10.1111/j.1365-3024.2007.00991.x
– volume: 42
  start-page: 206
  year: 1990
  ident: B12
  article-title: Distribution and etiology of leishmaniasis in Colombia
  publication-title: Am. J. Trop. Med. Hyg
  doi: 10.4269/ajtmh.1990.42.206
– volume: 2014
  start-page: 636039
  year: 2014
  ident: B52
  article-title: Involvement of different CD4(+) T cell subsets producing granzyme B in the immune response to Leishmania major antigens
  publication-title: Mediat. Inflamm
  doi: 10.1155/2014/636039
– volume: 31
  start-page: 432
  year: 2009
  ident: B25
  article-title: Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis
  publication-title: Parasite Immunol
  doi: 10.1111/j.1365-3024.2009.01125.x
– volume: 195
  start-page: 3748
  year: 2015
  ident: B42
  article-title: Inhibitory receptor expression on CD8+ T cells is linked to functional responses against Trypanosoma cruzi Antigens in chronic chagasic patients
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.1500459
– volume: 16
  start-page: 99
  year: 2015
  ident: B21
  article-title: Cutaneous leishmaniasis: recent developments in diagnosis and management
  publication-title: Am. J. Clin. Dermatol
  doi: 10.1007/s40257-015-0114-z
– volume: 9
  start-page: e0004178
  year: 2015
  ident: B40
  article-title: The immunology of a healing response in cutaneous Leishmaniasis treated with localized heat or systemic antimonial therapy
  publication-title: PLoS Negl. Trop. Dis
  doi: 10.1371/journal.pntd.0004178
– volume: 39
  start-page: 1700
  year: 2009
  ident: B4
  article-title: CTL quality and the control of human retroviral infections
  publication-title: Eur. J. Immunol
  doi: 10.1002/eji.200939451
– volume: 9
  start-page: e1003504
  year: 2013
  ident: B53
  article-title: Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1003504
– volume: 7
  start-page: 151
  year: 2016
  ident: B18
  article-title: Cutaneous Leishmaniasis vaccination: a matter of quality
  publication-title: Front. Immunol
  doi: 10.3389/fimmu.2016.00151
– volume: 191
  start-page: 5542
  year: 2013
  ident: B24
  article-title: Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.1301810
– volume: 31
  start-page: 423
  year: 2009
  ident: B67
  article-title: Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis
  publication-title: Parasite Immunol
  doi: 10.1111/j.1365-3024.2009.01116.x
– volume: 52
  start-page: 289
  year: 2012
  ident: B23
  article-title: Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients
  publication-title: Mol. Immunol
  doi: 10.1016/j.molimm.2012.05.021
– volume: 14
  start-page: 702
  year: 2012
  ident: B38
  article-title: Phenotyping of circulating CD8(+) T cell subsets in human cutaneous leishmaniasis
  publication-title: Microbes Infect
  doi: 10.1016/j.micinf.2012.02.006
– volume: 22
  start-page: 745
  year: 2004
  ident: B63
  article-title: Central memory and effector memory T cell subsets: function, generation, and maintenance
  publication-title: Annu. Rev. Immunol
  doi: 10.1146/annurev.immunol.22.012703.104702
– volume: 36
  start-page: 58
  year: 2006
  ident: B44
  article-title: PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis
  publication-title: Eur. J. Immunol
  doi: 10.1002/eji.200535458
– volume: 28
  start-page: 377
  year: 2012
  ident: B30
  article-title: T cell exhaustion in protozoan disease
  publication-title: Trends Parasitol
  doi: 10.1016/j.pt.2012.07.001
– ident: B70
SSID ssj0000702893
Score 2.3091729
Snippet The host immunological response is a key factor determining the pathogenesis of cutaneous leishmaniasis. It is known that a Th1 cellular response is associated...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 393
SubjectTerms biomarkers
CD8+ and CD4+ T-cells
Cellular and Infection Microbiology
Leishmania
leishmaniasis
paraflagellar rod protein-1
phenotype
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlUOil9F23TVChlxLM2pb8OiZOlrSUsoeE5ib0ZA1bbai9h_yS_t3OSN5lt5T20psfY1ueGWlmPONvCPnAuKuMalxqealS7soyVQoTjmDOGlVqxLjDaouv1dUN_3xb3u61-sKasAgPHBk3axVTWVtkLaLONLJoi9qZCm6qYduUAb0UbN5eMBXW4BozaCzmJSEKa2dO998VlnJh7SRr2YEdCnD9f_Ixfy-V3LM98yfk8eQ00rM42KfkgfXPyMPYRvL-Ofm5WFq_Hu_vek2lN3QOtip-4qOL2JJ7oGtHz_yI0JtpaDnvgLa74Kfhgu6iOaXXtLOr1UC3ArOGfuvHJf00lWt52sWydtp7uohwrEMk6TbgYtr1ZqBfbD8sEVJDDv3wgtzML6-7q3RquJBqXhVjqnNpwYPLtIMX1rDyGFk3MGNVpmDPcm5qx5SrZGMsz1Wda5cz6xTETFIqXbKX5MivvX1NKOMKfB0IvivpuNS2MZl1NgMBGgcuhUrIbMt-oSc0cmyKsRIQlaDARBCYQIGJILCEfNxdcReROP5Ce44S3dEhhnY4AJolJs0S_9KshLzf6oOAOYeJlMhLUUBY2VS8LouEvIr6sXsUw1UOYuCE1AeaczCWwzO-XwZcbwhFC8b4m_8x-LfkEbID_5rM23fkaPyxscfgPo3qJMyUXyiNGk8
  priority: 102
  providerName: Directory of Open Access Journals
Title Phenotypic and Functional Profiles of Antigen-Specific CD4+ and CD8+ T Cells Associated With Infection Control in Patients With Cutaneous Leishmaniasis
URI https://www.ncbi.nlm.nih.gov/pubmed/30510917
https://www.proquest.com/docview/2149864752
https://pubmed.ncbi.nlm.nih.gov/PMC6252334
https://doaj.org/article/9b3b0920976748a2927fd64f5ca29d55
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagCNQL4k0KVEbigqrQJHZeB4RKyqogQHvoit4iP9lIS7bdZCX2l_B3mbGzWxatOHDLw1Ycz4xnxjP-hpBXjNtMy8KGhqcy5DZNQykx4AjqrJCpQow7zLb4mp1N-KeL9OL6ePQwgd1O1w7rSU0Wszc_r1bvQODfoscJ-vbYquaHxCwtTItkJbtJboFeyrGewZfB2Hfrco5RNeZjlTs77pM7DJm0dOXLrtWUQ_PfZYL-nUn5h2oa3SN3B5uSnngmuE9umPYBue2rTK4ekl_jqWnn_eqyUVS0mo5AlfkdQDr2Fbs7Orf0pO0RmTN0FekttK1O-ZHrUJ0WR_ScVmY26-iankbTb00_pR-HbK6WVj7rnTYtHXu01s43qZZggZr5sqOfTdNNEXFDdE33iExGH86rs3CoxxAqniV9qGJhwMCLlIUfVrAwaZEXINAyknBnONe5ZdJmotCGxzKPlY2ZsRJcKiGkStljstfOW_OUUMYlmELgm2fCcqFMoSNjTVSIRFuwOGRAjtfTX6sBrBxrZsxqcFqQdrWjXY20qx3tAvJ60-PSA3X8o-17pOimHUJsuwfzxfd6kNi6lExGZRKVCHcEAyuT3OoMuFnBtU7TgLxc80MNIolxFj-XdQJeZ5HxPE0C8sTzx-ZTa_4KSL7FOVtj2X7TNlMH-w2easIYP_jvns_IPs4BnqSMy-dkr18szQswqXp56LYiDp28_AbnXSR7
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phenotypic+and+Functional+Profiles+of+Antigen-Specific+CD4%2B+and+CD8%2B+T+Cells+Associated+With+Infection+Control+in+Patients+With+Cutaneous+Leishmaniasis&rft.jtitle=Frontiers+in+cellular+and+infection+microbiology&rft.au=Egui%2C+Adriana&rft.au=Ledesma%2C+Dari%C3%A9n&rft.au=P%C3%A9rez-Ant%C3%B3n%2C+Elena&rft.au=Montoya%2C+Andr%C3%A9s&rft.date=2018-11-19&rft.pub=Frontiers+Media+S.A&rft.eissn=2235-2988&rft.volume=8&rft_id=info:doi/10.3389%2Ffcimb.2018.00393&rft_id=info%3Apmid%2F30510917&rft.externalDocID=PMC6252334
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2235-2988&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2235-2988&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2235-2988&client=summon